Novo Nordisk A S NVO
NYSE NVO
$38.89 -0.56 (-1.42%)
At close: Nov 19, 2026 · 4:00 PM EST

Novo Nordisk A S (NVO) Operating Expenses (2012 - 2016)

Updated

Novo Nordisk A S (NVO) reported Operating Expenses of $651 million for the quarter ended Dec 31, 2016.

Analysis

Novo Nordisk A S (NVO) Operating Expenses (2012 - 2016) Analysis & Trends

Over the twelve months ended Dec 31, 2016, Novo Nordisk A S's Operating Expenses came in at $36.36 billion; for the year ended Dec 31, 2013, it came in at $11.73 billion, up 7.7% from the prior year.

  • Operating Expenses has a four-year compound annual growth rate of 2.5% (years ended Dec 2009 to Dec 2013).
  • By year, Operating Expenses came in at $10.9 billion in the year ended Dec 31, 2012 (-15.3%), $12.87 billion in the year ended Dec 31, 2011 (+1.6%), $12.67 billion in the year ended Dec 31, 2010 (+19.2%) and $10.63 billion in the year ended Dec 31, 2009.
  • The figure for the quarter ended Dec 31, 2016 ranks as the highest quarterly Operating Expenses since the quarter ended Dec 31, 2014.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 651.00 Mn
Dec 31, 2014 13.76 Bn
Dec 31, 2012 10.90 Bn
API Access

Novo Nordisk A S Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NVO&period=max&api_key=YOUR_API_KEY